New Hunter Syndrome Drug Offers Hope as Weight Loss Injections Overtake Surgery

SHARE NOW

A rare genetic disorder that mostly affects boys just got its second-ever approved treatment. Hunter syndrome families have relied on a single approved drug since 2006, and this year’s new approval is giving them something they haven’t had in nearly two decades: a choice. It’s a big deal in the rare disease community, where almost 10% of Americans live with a condition that most often has no approved treatment at all.

On the same InvestigateTV+ episode, there’s a shift worth watching in weight loss care. A new study finds more Americans are choosing weight loss injections over bariatric surgery. It’s not just preference driving that decision. Insurance coverage can narrow the options before a patient ever gets to choose.

The episode wraps with two lighter features: a Portland business that turns vinyl records into mixtapes and Beal’s M&M Museum in Waggoner, where more than 5,000 M&M items are displayed wall to wall. Health, policy, and candy-coated nostalgia in one sitting. Which story hits closest to home for you?